PATENT CLAIM ANALYSIS

Application Number: 16018603
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["424", "078310"]

Abstract:
The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.

Claim (Index 11):
The method of  claim 1 , wherein said inflammatory mediator comprises one or more of cytokines, enzymes, prostaglandins, eicosanoids, leukotrienes, kinins, inflammatory mediator associated with anaphylaxis, coagulation factors, endotoxins, enterotoxins, lipopolysaccharide, cell fragments, bile salts, fatty acids, phospholipids, and interferon and immunomodulatory antibodies.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 94.0
- Lexical Diversity: 1.30952
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15635517', '13637775', '14238548', '13344166', '13506875']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.791284276197195
- 35 USC 102 Novelty (BERT): 0.5730775995272454
- Combined Prediction Score: 0.7694636085302
- Mean Citation Score: 374.67719000000005
- Max Citation Score: 502.80475
- Similarity Product: 371.5546499109269

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test